Robin L. Smith

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Melville, NY
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Keith A. Kucinski, attorney-in fact for Robin Smith
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Robin L. Smith

Form 4 holding Director

Celularity Inc

Security class
Class A Common Stock
Shares / value
236,066
Estimated value
$58,780
Report date
14 Jun 2023
Price
$0.2490
Ownership
Direct
Form 4 holding Director

Celularity Inc

Security class
Stock Option (Right to Buy)
Shares / value
277,778
Estimated value
Report date
14 Jun 2023
Price
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Director

Sorrento Therapeutics, Inc.

Security class
Stock Options
Shares / value
0
Estimated value
Report date
03 Sep 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Robin L. Smith

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .